Hernández-Herrera RJ, Hernández-Aguirre LM, Castillo-Martínez NE, Rosa-Mireles N, Martínez-Elizondo J, Alcalá-Galván LG, Estrella-Garza MC, Hernández-Núñez R, Torcida-González ME

Language: Spanish
References: 15
Page: 421-426
PDF size: 140.48 Kb.

ABSTRACT

Introduction: congenital hearing loss is a serious health problem affecting 1 to 3 out of 1000 neonates, and is the most common cause of neurosensorial defect; hearing screening helps to identifying early permanent childhood hearing loss (HL).
Objective: to establish the percentage of hearing loss in newborns with and without risk factors through hearing screening.
Material and methods: by using a cross-sectional design, a group of neonates with risk factors and a group without risk factors were included in a two-stage hearing screening program. The otoacoustic emissions (OAEs) procedure was done in the first stage and the automated auditory brain stem response (AABR) procedure in the second stage. The latter was performed only in children with abnormal results in the OAE procedure.
Results: 518 newborns were included in the hearing screening procedures; 220 neonates with risk factors and 298 without risk factors. 35 had + OAE test and the ABBR procedure helped to confirm that 30 neonates had hearing loss, 26 had bilateral HL; 10 had asymmetric HL; 4 had unilateral HL and 5 were false positives. The AABR procedure ascertained 17 HL cases with a threshold › 40 dB (86 per 100 000), 11 cases (55 per 100 000) in the risk group and 6 (30 per 100 000) in the non-risk group (p ‹ 0.05). The main risk factors were prematurity, craniofacial anomalies, mechanical ventilation, prescription of amikacin and cytomegalovirus infection.
Conclusions: the two-stage hearing screening program ascertained that 5.7 % had HL. AABR (threshold ›: 40 dB) confirmed 17 (86 per 100 000) neonates with HL, which was more frequent in the risk group (5 %) than in the non-risk group (2 %; p ‹ 0.05).

REFERENCES

1. Hayes D. Current status of universal newborn hearing screening. Curr Opin Otolaryngol Head Neck Surg 2002; 10:382-386.

2. Kezirian EJ, White KR, Yueh B, Sullivan SD. Cost and cost-effectiveness of universal screening for hearing loss in newborns. Otolaryngol Head Neck Surg 2001;124:359-367.

3. Incesulu A, Vural M, Erkman U. Children with cochlear implants: parental perspective. Otol Neurol 2003;24:605-611.

4. Moyer V. Controlled trial of universal neonatal screening for early identification of permanent childhood hearing impairment. J Pediatr 1999; 135:129-130.

5. Kennedy C. Neonatal screening for hearing impairment. Arch Dis Child 2000;83:377-382.

6. Kennedy C, McCann D. Universal neonatal hearing screening moving from evidence to practice. Arch Dis Child Fetal Neonatal Ed 2004;89:F378-383.

7. Martínez-Cruz CF, Fernández-Carrocera LA. Evaluación audiológica del niño con peso extremadamente bajo al nacer. Bol Med Hosp Infant Mex 2001;58:843-852.

8. Korres SG, Balatsouras DG, Lyra C, Kandiloros D, Ferekidis E. A comparison of automated auditory brainstem responses and transiently evoked otoacoustic emissions for universal newborn hearing screening. Med Sci Monit 2006;12:260-263.

9. Lima GM, Marba ST, Santos MF. Hearing screening in a neonatal intensive care unit. J Pediatr 2006;82:110-114.

10. Weichbold V, Nekahm-Heis D, Welzl-Mueller K. Universal newborn hearing screening and postnatal hearing loss. Pediatrics 2006;117:631-636.

11. Lieu JE, Karzon RK, Mange CC. Hearing screening in the neonatal intensive care unit: follow-up of referrals. Am J Audiol 2006;15:66-74.

12. Morton C. Genetics, genomics and gene discovery in the auditory system. Hum Mol Genet 2002; 11:1229-1240.

13. Van Riper L, Kileny P. ABR hearing screening for high risk infants. Am J Otology 1999;20:516-521.

14. Morton CC, Nance WE. Current concepts: newborn hearing screening – a silent revolution. N Engl J Med 2006;354:2151-2164.

15. Janssen T, Klein A, Gehr DD. Automated hearing threshold estimation in newborns using extrapolated DPOAE input/output functions. HNO 2003;51:971-980.